BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 21799368)

  • 1. 18F-FDG PET-CT in the diagnosis of tumor thrombus: can it be differentiated from benign thrombus?
    Sharma P; Kumar R; Jeph S; Karunanithi S; Naswa N; Gupta A; Malhotra A
    Nucl Med Commun; 2011 Sep; 32(9):782-8. PubMed ID: 21799368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of 18 F-FDG PET/CT in the diagnosis of benign vs. malignant tumor thrombus.
    Sarswat S; Khan D; Sagar S; Kumar R
    Nucl Med Commun; 2023 Aug; 44(8):726-731. PubMed ID: 37272295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of 18F-FDG PET/contrast-enhanced CT in detection of tumor thrombus.
    Lee EY; Khong PL
    Clin Nucl Med; 2013 Feb; 38(2):e60-5. PubMed ID: 23334142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions.
    Okada M; Shimono T; Komeya Y; Ando R; Kagawa Y; Katsube T; Kuwabara M; Yagyu Y; Kumano S; Imaoka I; Tsuchiya N; Ashikaga R; Hosono M; Murakami T
    Ann Nucl Med; 2009 Jun; 23(4):349-54. PubMed ID: 19340526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor thrombus: ancillary findings on FDG PET/CT in an oncologic population.
    Ravina M; Hess S; Chauhan MS; Jacob MJ; Alavi A
    Clin Nucl Med; 2014 Sep; 39(9):767-71. PubMed ID: 24999677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical efficacy of (18)F-FDG-PET/CT in benign and malignant musculoskeletal tumors.
    Shin DS; Shon OJ; Han DS; Choi JH; Chun KA; Cho IH
    Ann Nucl Med; 2008 Aug; 22(7):603-9. PubMed ID: 18756363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDG-PET/CT for diagnosis of primary ovarian cancer.
    Kitajima K; Suzuki K; Senda M; Kita M; Nakamoto Y; Onishi Y; Maeda T; Yoshikawa T; Ohno Y; Sugimura K
    Nucl Med Commun; 2011 Jul; 32(7):549-53. PubMed ID: 21407140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating between benign and malignant adrenal lesions.
    Ozcan Kara P; Kara T; Kara Gedik G; Kara F; Sahin O; Ceylan Gunay E; Sari O
    Nucl Med Commun; 2011 Feb; 32(2):106-12. PubMed ID: 21085046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of SUV(max) obtained by 18F-FDG PET/CT in patients with a solitary pancreatic lesion: predicting malignant potential and proliferation.
    Hu SL; Yang ZY; Zhou ZR; Yu XJ; Ping B; Zhang YJ
    Nucl Med Commun; 2013 Jun; 34(6):533-9. PubMed ID: 23503000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of 18F-FDG PET/CT in differentiating malignant from benign portal vein thrombosis.
    Hu S; Zhang J; Cheng C; Liu Q; Sun G; Zuo C
    Abdom Imaging; 2014 Dec; 39(6):1221-7. PubMed ID: 24913670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective evaluation of solitary thyroid nodule on 18F-FDG PET/CT and high-resolution ultrasonography.
    D'Souza MM; Marwaha RK; Sharma R; Jaimini A; Thomas S; Singh D; Jain M; Bhalla PJ; Tripathi M; Tiwari A; Mishra A; Mondal A; Tripathi RP
    Ann Nucl Med; 2010 Jun; 24(5):345-55. PubMed ID: 20373060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F- FDG-PET/CT for the diagnosis of tumor thrombosis.
    Davidson T; Goitein O; Avigdor A; Zwas ST; Goshen E
    Isr Med Assoc J; 2009 Feb; 11(2):69-73. PubMed ID: 19432032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of hexokinase-2 in giant cell tumor of bone is associated with false positive in bone tumor on FDG-PET/CT.
    Hoshi M; Takada J; Oebisu N; Hata K; Ieguchi M; Nakamura H
    Arch Orthop Trauma Surg; 2012 Nov; 132(11):1561-8. PubMed ID: 22825642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidental diagnosis of tumor thrombosis on FDG PET/CT imaging.
    Erhamamci S; Reyhan M; Nursal GN; Torun N; Yapar AF
    Rev Esp Med Nucl Imagen Mol; 2015; 34(5):287-94. PubMed ID: 26025479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of incidental focal hypermetabolic uptake in the breast as detected by 18F-FDG PET/CT: clinical significance and differential diagnosis.
    Chae EY; Cha JH; Kim HH; Shin HJ; Kim HJ; Oh HY; Koh YH; Moon DH
    Acta Radiol; 2012 Jun; 53(5):530-5. PubMed ID: 22593124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of 18F fluoro-2-dĂ©soxy-D-glucose positron emission tomography/computed tomography for the diagnosis of venous thromboembolism.
    Le Roux PY; Robin P; Delluc A; Tardy B; Abgral R; Couturaud F; Reffad A; Le Gal G; Salaun PY
    Thromb Res; 2015 Jan; 135(1):31-5. PubMed ID: 25455997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardized uptake value based evaluation of lymphoma by FDG and FLT PET/CT.
    Wang R; Zhu H; Chen Y; Li C; Li F; Shen Z; Tian J; Yu L; Xu B
    Hematol Oncol; 2014 Sep; 32(3):126-32. PubMed ID: 23996464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].
    Xu HF; Liu Y; Zhang JH; Zhou RS; Zhou FH; Yuan MH
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):108-11. PubMed ID: 15854393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of MR imaging and FDG-PET/CT in the differential diagnosis of benign and malignant vertebral compression fractures.
    Cho WI; Chang UK
    J Neurosurg Spine; 2011 Feb; 14(2):177-83. PubMed ID: 21214309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDG PET-CT in cervical cancer: relationship between primary tumor FDG uptake and metastatic potential.
    Yilmaz M; Adli M; Celen Z; Zincirkeser S; Dirier A
    Nucl Med Commun; 2010 Jun; 31(6):526-31. PubMed ID: 20215979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.